Buell Jennifer has filed 29 insider transactions across 3 companies since January 2023.
Most recent transaction: a tax payment of 10024 shares of MiNK Therapeutics, Inc. ($INKT) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | F | Common Stock | 10024 | $11.12 | 57,942.0000 | 4,694,155 | 14.75% | 0.21% |
| Jan. 2, 2026 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 4,694,155 | 9999.99% | 1.07% |
| Jan. 2, 2026 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Common Stock | 31474 | $11.12 | 67,966.0000 | 4,694,155 | 86.25% | 0.67% |
| Sept. 9, 2025 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | F | Common Stock | 5351 | $15.36 | 36,492.0000 | 3,966,392 | 12.79% | 0.13% |
| Sept. 9, 2025 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 3,966,392 | 9999.99% | 1.26% |
| Sept. 9, 2025 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Common Stock | 18229 | $15.36 | 41,913.0000 | 3,966,392 | 76.97% | 0.46% |
| May 2, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 581 | $3.11 | 19,738.0000 | 25,308,841 | 3.03% | 0.00% |
| April 18, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 869 | $2.08 | 19,157.0000 | 25,308,841 | 4.75% | 0.00% |
| April 4, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 1159 | $1.56 | 18,288.0000 | 25,308,841 | 6.77% | 0.00% |
| March 21, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 1123 | $1.61 | 17,129.0000 | 25,308,841 | 7.02% | 0.00% |
| March 7, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 409 | $2.35 | 15,646.0000 | 0 | 2.68% | 0.00% |
| Feb. 21, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 545 | $3.32 | 15,237.0000 | 0 | 3.71% | 0.00% |
| Feb. 21, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 626 | $3.32 | 15,318.0000 | 0 | 4.26% | 0.00% |
| Feb. 7, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 516 | $3.50 | 14,692.0000 | 0 | 3.64% | 0.00% |
| Jan. 24, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | F | Common Stock | 270 | $3.57 | 14,176.0000 | 0 | 1.87% | 0.00% |
| Jan. 24, 2025 | AGENUS INC | $AGEN | Buell Jennifer | Not found | A | Common Stock | 776 | $3.57 | 14,446.0000 | 0 | 5.68% | 0.00% |
| Nov. 14, 2024 | AGENUS INC | $AGEN | Buell Jennifer | Chairman Executive Council | A | Stock Option | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Protagenic Therapeutics, Inc.new | $PTIX | Buell Jennifer | Director | A | PTIX Common stock Options | 75000 | $1.74 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Stock Option | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Stock Option | 660919 | $0.00 | 660,919.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Restricted Stock Units | 695750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 11, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | J | Common Stock | 695750 | $0.00 | 232,165.0000 | 0 | 74.98% | 0.00% |
| Oct. 3, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | F | Common Stock | 65000 | $0.94 | 927,915.0000 | 0 | 6.55% | 0.00% |
| Oct. 2, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | F | Common Stock | 58550 | $1.04 | 992,915.0000 | 0 | 5.57% | 0.00% |
| Sept. 29, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | F | Common Stock | 25000 | $1.15 | 1,051,465.0000 | 0 | 2.32% | 0.00% |
| Sept. 27, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | M | Common Stock | 695750 | $0.00 | 1,076,465.0000 | 0 | 182.75% | 0.00% |
| Sept. 27, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | M | Restricted Stock Unit | 695750 | $0.00 | 695,750.0000 | 0 | 50.00% | 0.00% |
| Jan. 9, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Stock Option | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | MiNK Therapeutics, Inc. | $INKT | Buell Jennifer | Chief Executive Officer | A | Common Stock | 171990 | $2.32 | 380,715.0000 | 0 | 82.40% | 0.00% |